Division of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, USA.
David Geffen School of Medicine, University of California, Los Angeles, USA.
Trials. 2024 Sep 12;25(1):609. doi: 10.1186/s13063-024-08450-w.
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic pain condition creating a wide range of urologic and pain symptoms. There is currently limited evidence to understand the mechanisms of IC/BPS. There have been recent studies suggesting that altered function in brain motor areas, particularly the supplementary motor cortex (SMA), relates to altered bladder sensorimotor control and may play an important role in IC/BPS. This study aims to provide evidence that non-invasive stimulation targeting the motor cortex may help reduce IC/BPS pain, as well as better understand the neural mechanism by which this stimulation targets neuromuscular dysfunction. This study is a two-group quadruple-blinded randomized controlled trial (RCT) of active vs. sham repetitive transmagnetic stimulation (rTMS). In addition, our study will also include functional magnetic resonance imaging (fMRI), pelvic floor electromyography (EMG), pelvic exam, and outcome measures and questionnaires to further study outcomes.
All aspects of the study were approved by the Institutional Review Board of the University of Southern California (protocol HS-20-01021). All participants provided informed consent by the research coordinator/assistants. The results will be submitted for publication in peer-reviewed journals and disseminated at scientific conferences.
ClinicalTrials.gov NCT04734847. Registered on February 1, 2021.
间质性膀胱炎/膀胱疼痛综合征(IC/BPS)是一种慢性疼痛病症,会引起多种泌尿系统和疼痛症状。目前,对于 IC/BPS 的发病机制,我们的了解还很有限。最近有研究表明,大脑运动区(尤其是辅助运动皮层,SMA)功能的改变与膀胱感觉运动控制的改变有关,这可能在 IC/BPS 中起着重要作用。本研究旨在提供证据表明,针对运动皮层的非侵入性刺激可能有助于减轻 IC/BPS 疼痛,并更好地了解这种刺激针对神经肌肉功能障碍的神经机制。本研究是一项针对活跃组与假刺激组的双盲随机对照试验(RCT),比较重复经颅磁刺激(rTMS)的疗效。此外,我们的研究还将包括功能磁共振成像(fMRI)、盆底肌肌电图(EMG)、盆腔检查以及结果评估和问卷调查,以进一步研究结果。
该研究的所有方面均得到南加州大学机构审查委员会(protocol HS-20-01021)的批准。所有参与者均由研究协调员/助理征得知情同意。研究结果将提交给同行评议的期刊发表,并在科学会议上传播。
ClinicalTrials.gov NCT04734847。于 2021 年 2 月 1 日注册。